Karlygash N Tazhibayeva¹*, Galiya E Kaldygozova², Almas N Ormanov³, Assel D Sadykova⁴, Bolat B Daurenov⁵, Alizada F Kuliev⁵ and Aiman A Mussina⁶

¹Assistant-Professor, Khoja Akhmet Yassawi International Kazakh-Turkish University, Al-Farabi Kazakh National University, Shymkent City Cancer Center, Kazakhstan

*Corresponding Author: Karlygash N Tazhibayeva, Assistant-Professor, Khoja Akhmet Yassawi International Kazakh-Turkish University, Al-Farabi Kazakh National University, Shymkent City Cancer Center, Kazakhstan.

Received: March 09, 2022; Published: December 14, 2022

Abstract

Relevance: Ra is common COVID-19 began in the whole world at the beginning of 2020, and one of the most vulnerable subgroups of the population were identified oncological diseases. The purpose of the study: to study the risk of recurrence of COVID-19 in the subtype of swollen face in malignant diseases. and conduct monitoring with the help of the created registry "Can COVID" в г. Shymkent (Turkestan region).

Keywords: COVID-19; SARS-CoV-2; Swelling

References

1. Anil Iris., et al. “Coronavirus Cancer Monitoring Project, UK. Coronavirus cancer monitoring in the UK. Go back: and dr. (2020).
2. “British Cancer Monitoring Project: Protecting Cancer in the Age of COVID-19”. Lancet Oncology5 (2020): 622-624.
3. Go to: Oncologists in the UK are launching a joint project to monitor cancer patients with COVID-19. www.birmingham.ac.uk.
4. Liang Wenhua., et al. “Oncological patients with SARS-CoV-2 infection: national analysis in China”. The Lancet Oncology 3 (2020): 335-337.
5. Yu Jing., et al. “Transfer of SARS-CoV-2 to oncology patients at the tertiary level hospital in Wuhan, China”. JAMA Oncology7 (2020): 10.
6. “Cancer and coronavirus monitoring project About this reporting project”.
7. UK-Coronavirus-monitoring-cancer-scheme-letter-030420_nocontact.pdf Go to: Proponents of the coronavirus project.
8. “Report on Coronavirus Cancer in a British Coronavirus Cancer Monitoring Project”.
9. “Patients with known or suspected COVID-19. Short guide: providing a systemic anti-inflammatory treatment NICE Guide”. Www.nice.org.uk.
10. Lee Lennard YW., et al. “Mortality from COVID-19 in patients with cancer receiving chemotherapy or other contraceptive methods of treatment: prospective cohort study”. That Lancet10241 (2020): 1919-1926.
11. Kuderer Nicole M., et al. “Clinical effects of COVID-19 on cancer (CCC19): cohort study”. That Lancet10241 (2020): 1907-1918.
12. Vuagnat Perrin., et al. “COVID-19 in patients with breast cancer: cohort in hospitals of the Curie Institute in the Paris region”. Chest Cancer Research1 (2020).
13. “The study showed that patients with blood cancer were at a higher risk of dying from the coronavirus”. The Independent (2020).

Citation

Citation: Karlygash N Tazhibayeva. “A Modern Approach to the Detection of COVID-19 in Oncological Patients in Pandemic Conditions". Acta Scientific Gastrointestinal Disorders 6.1 (2023): 22-25.

Copyright

Copyright: © 2022 Karlygash N Tazhibayeva. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.